|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/454 | |||
| A61K 45/06 | |||
| A61P 3/00 |
| (11) | Number of the document | 1933818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06814470.8 |
| Date of filing the European patent application | 2006-09-12 | |
| (97) | Date of publication of the European application | 2008-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/035378 |
| Date | 2006-09-12 |
| (87) | Number | WO 2007/033112 |
| Date | 2007-03-22 |
| (30) | Number | Date | Country code |
| 715582 P | 2005-09-12 | US |
| (72) |
VERHELLE, Dominique, US
CHAN, Kyle, US
BRADY, Helen, US
|
| (73) |
CELGENE CORPORATION,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LOW PLASMA LEPTIN LEVELS |
| METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH LOW PLASMA LEPTIN LEVELS |